INS and type 2 diabetes mellitus: Immunization with SAS-adjuvanted OmpW elicited strong serum antibody responses, along with IFN-γ-secreting CD4+, CD8+, natural killer, and natural killer T cell responses against OmpW in non-insulin-resistant C57BL/6J and insulin-resistant C57BL/6J mouse models of Type 2 diabetes (53, 76).